glycyrrhizic acid has been researched along with hyperoside in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, G; Lu, D; Shi, T; Tian, S; Tu, D; Xu, X; Yang, J; Yang, Y; Zeng, H; Zhang, F; Zhang, W; Zhao, J; Zhao, S; Zheng, Y | 1 |
1 other study(ies) available for glycyrrhizic acid and hyperoside
| Article | Year |
|---|---|
Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Computational Biology; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Flavonoids; Glycyrrhizic Acid; Hesperidin; Humans; Male; Medicine, Chinese Traditional; Mice; Molecular Docking Simulation; Quercetin; Rabbits; RAW 264.7 Cells; SARS-CoV-2; Signal Transduction | 2021 |